{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:05:07Z","timestamp":1773353107875,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Does fertility preservation (FP) through oocyte cryopreservation provide realistic reproductive opportunities for diminished ovarian reserve (DOR)? Literature suggests cumulative live birth rates of 30\u201345% with 8\u201310 oocytes under 35\u00a0years old. Insufficient data exist to define whether DOR patients should be offered FP systematically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective single-center study analyzed data from 304 women undergoing oocyte cryopreservation (January 2016\u2013December 2024). Patients were stratified into cohort 1 (Anti-M\u00fcllerian hormone\u2014AMH\u2014\u2264\u20090.5\u00a0ng\/mL,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200949) and cohort 2 (AMH\u2009&gt;\u20090.5\u00a0ng\/mL,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009255). Primary outcomes included retrieved oocytes (RO) and vitrified oocytes (VO). Secondary outcome examined DuoStim results. Statistical analysis included correlation assessments, ANCOVA, and multiple linear regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      DOR patients achieved lower oocyte yields compared to cohort 2 (RO: 3.1\u2009\u00b1\u20092.3 vs. 9.0\u2009\u00b1\u20096.5; VO: 2.3\u2009\u00b1\u20091.9 vs. 7.4\u2009\u00b1\u20095.1;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), despite higher gonadotropin doses. AMH strongly correlated with RO (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009=\u20090.636,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and VO (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009=\u20090.624,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Linear regression confirmed AMH (\n                      <jats:italic>B<\/jats:italic>\n                      \u2009=\u20091.151,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and age (\n                      <jats:italic>B<\/jats:italic>\n                      \u2009=\u2009\u2009\u2212\u20090.139,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) as significant predictors of VO. In DuoStim subgroup, DOR patients achieved 3.3\u2009\u00b1\u20092.1 total VO compared to 6.9\u2009\u00b1\u20093.3 in cohort 2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DOR patients achieve oocyte yields substantially below thresholds associated with reasonable live birth rates, raising concerns regarding FP efficacy. These findings highlight the need for personalized counseling that considers individual patient characteristics and provides evidence-based, realistic expectations for FP. A revision of current AMH thresholds may improve patient selection and cost-effectiveness of FP programs. Younger DOR patients may benefit from oocyte cryopreservation for FP, emphasizing the importance of age stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10815-025-03779-w","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T23:52:21Z","timestamp":1766706741000},"page":"865-872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fertility preservation in women with diminished ovarian reserve: evaluating the AMH criteria"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-129X","authenticated-orcid":false,"given":"Maria Elisabetta","family":"Coccia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3059-9441","authenticated-orcid":false,"given":"Benedetta","family":"Gabbrielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Cutajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Piazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Evangelisti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4189-5969","authenticated-orcid":false,"given":"Laura","family":"Badolato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-245X","authenticated-orcid":false,"given":"Patrizia","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-8883","authenticated-orcid":false,"given":"Rossella","family":"Fucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-9387","authenticated-orcid":false,"given":"Carlo","family":"Bulletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"3779_CR1","doi-asserted-by":"publisher","unstructured":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee (2014) Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril 101:633\u2013634. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.032","DOI":"10.1016\/j.fertnstert.2013.12.032"},{"key":"3779_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5005\/jp-journals-10016-1060","volume":"4","author":"M Arora","year":"2013","unstructured":"Arora M, Kaur M. Diminished ovarian reserve, causes, assessment and management. International Journal of Infertility & Fetal Medicine. 2013;4:45\u201355. https:\/\/doi.org\/10.5005\/jp-journals-10016-1060.","journal-title":"International Journal of Infertility & Fetal Medicine"},{"key":"3779_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1210\/er.2009-0006","volume":"30","author":"FJ Broekmans","year":"2009","unstructured":"Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30:465\u201393. https:\/\/doi.org\/10.1210\/er.2009-0006.","journal-title":"Endocr Rev"},{"key":"3779_CR4","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0140-6736(86)90989-X","volume":"327","author":"C Chen","year":"1986","unstructured":"Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;327:884\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(86)90989-X.","journal-title":"Lancet"},{"key":"3779_CR5","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1093\/humrep\/dey321","volume":"33","author":"A Cobo","year":"2018","unstructured":"Cobo A, Garc\u00eda-Velasco J, Domingo J, Pellicer A, Remoh\u00ed J. Elective and onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018;33:2222\u201331. https:\/\/doi.org\/10.1093\/humrep\/dey321.","journal-title":"Hum Reprod"},{"key":"3779_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.fertnstert.2021.02.006","volume":"115","author":"A Cobo","year":"2021","unstructured":"Cobo A, Garc\u00eda-Velasco JA, Remoh\u00ed J, Pellicer A. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. Fertil Steril. 2021;115:1091\u2013101. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.006.","journal-title":"Fertil Steril"},{"key":"3779_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12094-009-0331-0","volume":"11","author":"J Domingo","year":"2009","unstructured":"Domingo J, Ayll\u00f3n Y, Domingo S, Cobo A, Crespo J, Pellicer A. New approaches to female fertility preservation. Clin Transl Oncol. 2009;11:154\u20139. https:\/\/doi.org\/10.1007\/s12094-009-0331-0.","journal-title":"Clin Transl Oncol"},{"key":"3779_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.fertnstert.2015.10.026","volume":"105","author":"JO Doyle","year":"2016","unstructured":"Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril. 2016;105:459-466.e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.10.026.","journal-title":"Fertil Steril"},{"key":"3779_CR9","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria\u2020. Hum Reprod. 2011;26:1616\u201324. https:\/\/doi.org\/10.1093\/humrep\/der092.","journal-title":"Hum Reprod"},{"key":"3779_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","volume":"101","author":"JM Franasiak","year":"2014","unstructured":"Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101:656-663.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.11.004.","journal-title":"Fertil Steril"},{"key":"3779_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/humrep\/dex008","volume":"32","author":"RH Goldman","year":"2017","unstructured":"Goldman RH, Racowsky C, Farland LV, Munn\u00e9 S, Ribustello L, Fox JH. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod. 2017;32:853\u20139. https:\/\/doi.org\/10.1093\/humrep\/dex008.","journal-title":"Hum Reprod"},{"key":"3779_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.fertnstert.2024.01.004","volume":"121","author":"E Hagege","year":"2024","unstructured":"Hagege E, Sokteang S, Ayoubi JM, de Ziegler D. Fertility preservation counseling: old indications, novel perspectives. Fertil Steril. 2024;121:553\u20134. https:\/\/doi.org\/10.1016\/j.fertnstert.2024.01.004.","journal-title":"Fertil Steril"},{"key":"3779_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/humupd\/dmae009","volume":"30","author":"A Hirsch","year":"2024","unstructured":"Hirsch A, Hirsh Raccah B, Rotem R, Hyman JH, Ben-Ami I, Tsafrir A. Planned oocyte cryopreservation: a systematic review and meta-regression analysis. Hum Reprod Update. 2024;30:558\u201368. https:\/\/doi.org\/10.1093\/humupd\/dmae009.","journal-title":"Hum Reprod Update"},{"key":"3779_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0974-1208.183514","volume":"9","author":"PR Jirge","year":"2016","unstructured":"Jirge PR. Poor ovarian reserve. J Hum Reprod Sci. 2016;9:63\u20139. https:\/\/doi.org\/10.4103\/0974-1208.183514.","journal-title":"J Hum Reprod Sci"},{"key":"3779_CR15","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/humrep\/14.12.3077","volume":"14","author":"L Kuleshova","year":"1999","unstructured":"Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A. Birth following vitrification of a small number of human oocytes: case report. Hum Reprod. 1999;14:3077\u20139. https:\/\/doi.org\/10.1093\/humrep\/14.12.3077.","journal-title":"Hum Reprod"},{"key":"3779_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","volume":"119","author":"A La Marca","year":"2012","unstructured":"La Marca A, Papaleo E, Grisendi V, Argento C, Giulini S, Volpe A. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. BJOG: An International Journal of Obstetrics & Gynaecology. 2012;119:1171\u20139. https:\/\/doi.org\/10.1111\/j.1471-0528.2012.03412.x.","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"3779_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113\u201330. https:\/\/doi.org\/10.1093\/humupd\/dmp036.","journal-title":"Hum Reprod Update"},{"key":"3779_CR18","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/humrep\/dez100","volume":"34","author":"YJ Law","year":"2019","unstructured":"Law YJ, Zhang N, Venetis CA, Chambers GM, Harris K. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221\u2009221 treatment cycles. Hum Reprod. 2019;34:1778\u201387. https:\/\/doi.org\/10.1093\/humrep\/dez100.","journal-title":"Hum Reprod"},{"key":"3779_CR19","doi-asserted-by":"publisher","first-page":"17723","DOI":"10.1038\/s41598-022-22859-w","volume":"12","author":"HJ Lee","year":"2022","unstructured":"Lee HJ, Noh HK, Joo JK. Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria. Sci Rep. 2022;12:17723. https:\/\/doi.org\/10.1038\/s41598-022-22859-w.","journal-title":"Sci Rep"},{"key":"3779_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012693.pub3","author":"O Ngwenya","year":"2024","unstructured":"Ngwenya O, Lensen SF, Vail A, Mol BWJ, Broekmans FJ, Wilkinson J. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI). Cochrane Database Syst Rev. 2024. https:\/\/doi.org\/10.1002\/14651858.CD012693.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"3779_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa009","volume":"2020","author":"E Bosch","year":"2020","unstructured":"Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI(\u2020). Hum Reprod Open. 2020;2020:hoaa009. https:\/\/doi.org\/10.1093\/hropen\/hoaa009.","journal-title":"Hum Reprod Open"},{"key":"3779_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae065","volume":"2024","author":"N Panay","year":"2024","unstructured":"Panay N, Anderson RA, Bennie A, Cedars M, Davies M, Ee C, et al. Evidence-based guideline: premature ovarian insufficiency\u2020,\u2021. Hum Reprod Open. 2024;2024:hoae065. https:\/\/doi.org\/10.1093\/hropen\/hoae065.","journal-title":"Hum Reprod Open"},{"key":"3779_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.5935\/1518-0557.20200100","volume":"25","author":"M Roque","year":"2021","unstructured":"Roque M, Haahr T, Esteves SC, Humaidan P. The POSEIDON stratification - moving from poor ovarian response to low prognosis. JBRA Assisted Reproduction. 2021;25:282\u201392. https:\/\/doi.org\/10.5935\/1518-0557.20200100.","journal-title":"JBRA Assisted Reproduction"},{"key":"3779_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/00016340701194948","volume":"86","author":"P Saldeen","year":"2007","unstructured":"Saldeen P, K\u00e4llen K, Sundstr\u00f6m P. The probability of successful IVF outcome after poor ovarian response. Acta Obstet Gynecol Scand. 2007;86:457\u201361. https:\/\/doi.org\/10.1080\/00016340701194948.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3779_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","volume":"8","author":"ER te Velde","year":"2002","unstructured":"te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141\u201354. https:\/\/doi.org\/10.1093\/humupd\/8.2.141.","journal-title":"Hum Reprod Update"},{"key":"3779_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.rbmo.2012.11.020","volume":"26","author":"B Xu","year":"2013","unstructured":"Xu B, Li Y. Flexible ovarian stimulation in a poor responder: a case report and literature review. Reprod Biomed Online. 2013;26:378\u201383. https:\/\/doi.org\/10.1016\/j.rbmo.2012.11.020.","journal-title":"Reprod Biomed Online"},{"key":"3779_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/humupd\/dmz046","volume":"26","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang C, Shu J, Guo J, Chang H-M, Leung PCK, et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum Reprod Update. 2020;26:247\u201363. https:\/\/doi.org\/10.1093\/humupd\/dmz046.","journal-title":"Hum Reprod Update"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03779-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03779-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:18:34Z","timestamp":1773314314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03779-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3779"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03779-w","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local Ethics Committee (15404 CAM-BIO) and conducted in compliance with the Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided informed consent before enrollment in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}